Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Wah Yan Healthcare ( (HK:0648) ) just unveiled an update.
SoftMedx Healthcare Limited said shareholders overwhelmingly approved a specific mandate at an extraordinary general meeting held in Hong Kong on 30 March 2026. All directors attended, no shareholders were required to abstain, and the mandate received 99.99% of votes cast, signaling strong investor support for the board’s proposed capital-related arrangements.
The company reported that all eligible shares were entitled to vote and that an independent share registrar acted as scrutineer, confirming the poll results. The decisive backing for the specific mandate is expected to give the board greater flexibility in future share or financing actions, potentially influencing the company’s capital structure and strategic options.
More about China Wah Yan Healthcare
SoftMedx Healthcare Limited operates in the healthcare sector and is listed on the Hong Kong Stock Exchange. The company is governed by a board comprising one executive director and three independent non-executive directors, reflecting a standard corporate governance structure for a Hong Kong-listed healthcare firm.
Average Trading Volume: 2,265,437
Technical Sentiment Signal: Sell
Current Market Cap: HK$552.8M
For a thorough assessment of 0648 stock, go to TipRanks’ Stock Analysis page.